Oncology/Hematology

Skin Cancer

Latest AI and machine learning research in skin cancer for healthcare professionals.

10,590 articles
Stay Ahead - Weekly Skin Cancer research updates
Subscribe
Browse Categories
Showing 1081-1100 of 10,590 articles

Gene-environment interaction analysis via deep learning.

Gene-environment (G-E) interaction analysis plays an important role in studying complex diseases. Extensive methodological research has been conducted on G-E interaction analysis, and the existing methods are mostly based on regression techniques. In many fields including biomedicine and omics, it has been increasingly recognized that deep learning may outperform regression with its unique flexibi...

Feb 19 2023 36807383

Neural-Network-Based Immune Optimization Regulation Using Adaptive Dynamic Programming.

This article investigates optimal regulation scheme between tumor and immune cells based on the adaptive dynamic programming (ADP) approach. The therapeutic goal is to inhibit the growth of tumor cells to allowable injury degree and maximize the number of immune cells in the meantime. The reliable controller is derived through the ADP approach to make the number of cells achieve the specific ideal...

Feb 15 2023 35767503
Ensemble-based genetic algorithm explainer with automized image segmentation: A case study on melanoma detection dataset.

Explainable Artificial Intelligence (XAI) makes AI understandable to the human user particularly when the model is complex and opaque. Local Interpret...

Feb 5 2023 36764157
Molecular MRI-Based Monitoring of Cancer Immunotherapy Treatment Response.

Immunotherapy constitutes a paradigm shift in cancer treatment. Its FDA approval for several indications has yielded improved prognosis for cases wher...

Feb 5 2023 36834563
DapNet-HLA: Adaptive dual-attention mechanism network based on deep learning to predict non-classical HLA binding sites.

Human leukocyte antigen (HLA) plays a vital role in immunomodulatory function. Studies have shown that immunotherapy based on non-classical HLA has es...

Feb 3 2023 36740003
Robotics and cybersurgery in ophthalmology: a current perspective.

Ophthalmology is one of the most enriched fields, allowing the domain of artificial intelligence to be part of its point of interest in scientific res...

Jan 13 2023 36637738
Intraclass Clustering-Based CNN Approach for Detection of Malignant Melanoma.

This paper describes the process of developing a classification model for the effective detection of malignant melanoma, an aggressive type of cancer ...

Jan 13 2023 36679721
Advances in artificial intelligence to predict cancer immunotherapy efficacy.

Tumor immunotherapy, particularly the use of immune checkpoint inhibitors, has yielded impressive clinical benefits. Therefore, it is critical to accu...

Jan 4 2023 36685496
Artificial Intelligence and Advanced Melanoma: Treatment Management Implications.

Artificial intelligence (AI), a field of research in which computers are applied to mimic humans, is continuously expanding and influencing many aspec...

Dec 8 2022 36552729
Plasma cell subtypes analyzed using artificial intelligence algorithm for predicting biochemical recurrence, immune escape potential, and immunotherapy response of prostate cancer.

BACKGROUND: Plasma cells as an important component of immune microenvironment plays a crucial role in immune escape and are closely related to immune ...

Dec 8 2022 36569837
Ensemble deep learning enhanced with self-attention for predicting immunotherapeutic responses to cancers.

INTRODUCTION: Despite the many benefits immunotherapy has brought to patients with different cancers, its clinical applications and improvements are s...

Dec 1 2022 36532083
A deep learning model based on whole slide images to predict disease-free survival in cutaneous melanoma patients.

The application of deep learning on whole-slide histological images (WSIs) can reveal insights for clinical and basic tumor science investigations. Fi...

Nov 27 2022 36437296
Multi-site cross-organ calibrated deep learning (MuSClD): Automated diagnosis of non-melanoma skin cancer.

Although deep learning (DL) has demonstrated impressive diagnostic performance for a variety of computational pathology tasks, this performance often ...

Nov 24 2022 36516556
Development of an automated combined positive score prediction pipeline using artificial intelligence on multiplexed immunofluorescence images.

Immunotherapy targeting immune checkpoint proteins, such as programmed cell death ligand 1 (PD-L1), has shown impressive outcomes in many clinical tri...

Nov 24 2022 36502695
Interpretability-Based Multimodal Convolutional Neural Networks for Skin Lesion Diagnosis.

Skin lesion diagnosis is a key step for skin cancer screening, which requires high accuracy and interpretability. Though many computer-aided methods, ...

Nov 18 2022 34546933
Artificial intelligence for prediction of response to cancer immunotherapy.

Artificial intelligence (AI) indicates the application of machines to imitate intelligent behaviors for solving complex tasks with minimal human inter...

Nov 11 2022 36372326
Quantitative Radiological Features and Deep Learning for the Non-Invasive Evaluation of Programmed Death Ligand 1 Expression Levels in Gastric Cancer Patients: A Digital Biopsy Study.

RATIONALE AND OBJECTIVES: Programmed Death-Ligand 1 (PD-L1) is an important biomarker for patient selection of immunotherapy in gastric cancer (GC). T...

Nov 8 2022 36369191
Deep learning-based image analysis predicts PD-L1 status from H&E-stained histopathology images in breast cancer.

Programmed death ligand-1 (PD-L1) has been recently adopted for breast cancer as a predictive biomarker for immunotherapies. The cost, time, and varia...

Nov 8 2022 36347854
Microfluidics guided by deep learning for cancer immunotherapy screening.

Immunocyte infiltration and cytotoxicity play critical roles in both inflammation and immunotherapy. However, current cancer immunotherapy screening m...

Nov 7 2022 36343225
Deep learning to estimate durable clinical benefit and prognosis from patients with non-small cell lung cancer treated with PD-1/PD-L1 blockade.

Different biomarkers based on genomics variants have been used to predict the response of patients treated with PD-1/programmed death receptor 1 ligan...

Nov 7 2022 36420269
Browse Categories